Navigation Links
New cancer drug shows promise for treating advanced melanoma
Date:6/2/2013

Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.

The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr. Antoni Ribas, professor of medicine in the UCLA division of hematology-oncology, who led the research. Following Ribas' presentation, the study was published online ahead of press in the New England Journal of Medicine.

The results are from the first clinical trial of the drug lambrolizumab (MK3475), which was discovered and developed by Merck. Researchers analyzed 135 patients with advanced metastatic melanoma who were divided into three groups with different treatment regimens.

Overall, 38 percent of patients taking lambrolizumab saw confirmed improvement of their cancer across all dose levels. Of those taking the lowest dose of lambrolizumab, 25 percent showed improvement, while 52 percent of those who received the highest dose improved. The rate of any tumor response across all patients was 77 percent. Researchers have not yet determined the average duration of response to the drug, because only five patients who had initial responses were taken off the study after their cancers got worse. To date, the longest response has been over one year.

Side effects with lambrolizumab are usually mild and easily managed. These include fatigue, fever, skin rash, loss of skin color and muscle weakness. Thirteen percent of patients had side effects that were more severe, including inflammation of the lung or kidney, and thyroid problems.

"This study is showing the highest rate of durable melanoma responses of any drug we have tested thus far for melanoma, and it is doing it without serious side effects in the great majority of patients," Ribas said.

'/>"/>
Contact: Shaun Mason
smason@mednet.ucla.edu
University of California - Los Angeles
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Some patients with treatment-resistant colorectal cancers may have a new option
2. Abnormalities in HER2 gene found in wide variety of advanced cancers
3. New Drug May Slow Advanced Ovarian Cancer
4. Doubling Time on Tamoxifen Cuts Odds for Breast Cancers Return: Study
5. MGH-led studies shed new light on targeted lung cancer therapy
6. No increased risk of infection for long-term sex partners of people with HPV-related oral cancers
7. Likelihood of Spousal HPV Oral Infection, Predictors of Melanoma and Throat Cancer, Preventing Cancer Readmissions
8. Spousal oral HPV, predictors of melanoma and throat cancer, preventing cancer readmissions
9. New drug improves progression-free survival, shrinks tumors in rare cancer for first time
10. Voices Against Brain Cancer Comments on New Potential Development in Brain Cancer Treatment
11. National Camp Series (NCS) Associate Chris Husby Joins Kicking For The Dream’s Effort to Fight Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Caicos Islands, BWI (PRWEB) , ... July 31, 2015 , ... The Venetian on Grace ... fall, 2015. Guests who stay at the Venetian will save 40% on their stay ... fall months are always quiet in the Turks & Caicos, providing a chance to reconnect ...
(Date:7/30/2015)... Texas (PRWEB) , ... July 30, 2015 , ... ... Path Institute (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that data ... have been published for use on the CDISC website . These three ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zaca Life has created Recovery ... no water needed, the refreshing berry-flavored tablets are the perfect travel companion. , ... ingredients that may help with body detoxification, protection and hydration,” said Mark Aleks, ...
(Date:7/30/2015)... Los Angeles, CA (PRWEB) , ... July 30, 2015 , ... ... driverless cars on an upcoming dedicated web site. As discussed in a June 8, ... of the minor collisions reported so far have been caused by its computer-driven cars, ...
(Date:7/30/2015)... , ... July 30, 2015 ... ... a video, “Beachside Nursing Center,” to announce its position as one of ... Beachside's administrator and staff members support the CMS rating system, which monitors ...
Breaking Medicine News(10 mins):Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Beachside Nursing Center Releases New Video 2
... , OWINGS MILLS, Md., July 23 Medifast, Inc. (NYSE: ... 2009 financial results for the period ended June 30, 2009 on Thursday, July ... a conference call and web cast to discuss the results on Thursday, July ... Interested parties can access the call by dialing (877) 407-0782 or (201) 689-8567, ...
... Gentiva Health Services, Inc. (Nasdaq: GTIV ), a ... has signed a definitive agreement to purchase Magna Home Health, a ... west central Alabama. Both states require a certificate of need (CON) ... , With the addition of Magna,s ...
... WILMINGTON, Del., July 23 AstraZeneca (NYSE: ... program by immediately extending assistance to qualifying patients who have ... a change in marital status or family size. , ... change in income or family size had difficulty applying to ...
... , , ... world,s leading research and advisory firms focusing on pharmaceutical and ... Abilify has grown in the first three lines of therapy ... schizophrenia patients. Abilify is second to risperidone (Janssen,s Risperdal, generics) ...
... , , , ... Fighters (IAFF) and Masimo jointly announced the launch of a new international ... dangers of carbon monoxide (CO) and reducing known risk factors that unnecessarily ... kicked off at the biennial IAFF EMS Conference in Miami Beach, Florida, ...
... , , CHARLOTTE, N.C., July 23 MedCath Corporation (Nasdaq: ... to discuss results from its third quarter ended June 30, 2009. The company will issue a ... What: Third Quarter Earnings Conference ... 2009, How: Dial-in conference call, ...
Cached Medicine News:Health News:Medifast, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday, July 30, 2009 2Health News:Gentiva(R) Health Services Signs Agreement to Acquire Home Health Agency with Offices in Mississippi and Alabama 2Health News:Gentiva(R) Health Services Signs Agreement to Acquire Home Health Agency with Offices in Mississippi and Alabama 3Health News:AstraZeneca Expands Prescription Savings Program 2Health News:Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia 2Health News:Abilify Has Made Strong Gains in Patient Share Across All Lines of Therapy Since Last Year's Analysis of Prescribing Trends in Schizophrenia 3Health News:The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters 2Health News:The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters 3Health News:The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters 4Health News:The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters 5Health News:The International Association of Fire Fighters and Masimo Team Up on a New Global Campaign to Raise Awareness of Carbon Monoxide-Related Death and Injury Risks for Fire Fighters 6Health News:MedCath Corporation to Hold Conference Call on Third Quarter Results 2
(Date:7/30/2015)... , July 30, 2015  ResMed (NYSE: ... signed a definitive agreement to acquire Curative ... ventilation and sleep-disordered breathing medical devices and ... market reputation in China, combined with ResMed,s global leadership in sleep and ... China suffering from ...
(Date:7/30/2015)... bring you a special edition of #MedicareMonday on Medicare,s 50 th anniversary. As ... resources and continue highlighting the success of the prescription drug benefit, commonly referred to ... our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... THOUSAND OAKS, Calif. , July 30, 2015  Amgen ... Fred Hassan , partner and managing director of Warburg Pincus ... "We are pleased to welcome Fred Hassan and ... to the Amgen Board," said Robert A. Bradway , ... expertise and commitment to innovation will serve Amgen well." ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3
... Osteotech, Inc. (Nasdaq: OSTE ), a ... regenerative healing, announced today that its patent supporting the ... the Research and Development Council of New Jersey,s 31st ...  Osteotech was chosen from a broad field of nominees ...
... Dendreon Corporation (Nasdaq: DNDN ) today reported ... the third quarter ended September 30, 2010 was $20.2 million ... Revenue for the nine months ended September 30, 2010 was ... September 30, 2009.   Revenue from sales of ...
Cached Medicine Technology:Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 2Osteotech's Plexur M® Technology Wins Thomas Alva Edison Patent Award from the New Jersey Research and Development Council 3Dendreon Reports Third Quarter 2010 Financial Results 2Dendreon Reports Third Quarter 2010 Financial Results 3Dendreon Reports Third Quarter 2010 Financial Results 4
Auto Refkeratomoeter...
... The InfusO.R. Pump is a ... aid in the administration of ... anesthetic procedures. It provides for ... muscle relaxants, and vasoactive drugs ...
Developed to meet the infusion needs in NICU, Anesthesia and Critical Care, the AUTO SYRINGE AS50 Infusion Pump delivers precise, controlled infusions....
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
Medicine Products: